Similarly, piR-823 increases glucose-6-phosphate dehydrogenase (G6PD) expression, which in turn increases the consumption of glucose by cancer cells while decreasing the amount of intracellular reactive oxygen species (ROS). This evidence concerns the gene PIR and cancer.